Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization
about
Smoking cessation therapy during pregnancyNicotine addictionA C. elegans model of nicotine-dependent behavior: regulation by TRP-family channelsNicotine binding to brain receptors requires a strong cation-pi interactionIn vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptorsMammalian nicotinic acetylcholine receptors: from structure to functionCrucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administrationVarenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherenceMolecular mechanisms underlying behaviors related to nicotine addictionMolecules and circuits involved in nicotine addiction: The many faces of smokingInside-out neuropharmacology of nicotinic drugsPreclinical evidence that activation of mesolimbic alpha 6 subunit containing nicotinic acetylcholine receptors supports nicotine addiction phenotypeA conserved dopamine-cholecystokinin signaling pathway shapes context-dependent Caenorhabditis elegans behaviorAlcohol and nicotine interactions: pre-clinical models of dependenceMolecular actions of smoking cessation drugs at 4 2 nicotinic receptors defined in crystal structures of a homologous binding proteinX-ray structure of the human α4β2 nicotinic receptorThe CHRNA5-A3-B4 Gene Cluster and Smoking: From Discovery to TherapeuticsDopaminergic and cholinergic learning mechanisms in nicotine addictionNicotinic receptor modulation to treat alcohol and drug dependenceThe role of the habenula in drug addiction.The habenulo-interpeduncular pathway in nicotine aversion and withdrawalGenetics of smoking and depressionWill chronic e-cigarette use cause lung disease?L-theanine inhibits nicotine-induced dependence via regulation of the nicotine acetylcholine receptor-dopamine reward pathwayADHD and smoking: from genes to brain to behaviorA candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addictionIdentification of a negative allosteric site on human α4β2 and α3β4 neuronal nicotinic acetylcholine receptorsLow dose nicotine and antagonism of β2 subunit containing nicotinic acetylcholine receptors have similar effects on affective behavior in micePresynaptic targeting of alpha4beta 2 nicotinic acetylcholine receptors is regulated by neurexin-1betaIn vitro and ex vivo analysis of CHRNA3 and CHRNA5 haplotype expressionConstitutional mechanisms of vulnerability and resilience to nicotine dependenceCognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.Breaking barriers in the genomics and pharmacogenetics of drug addictionNew insights into the genetics of addictionGene-gene interactions among CHRNA4, CHRNB2, BDNF, and NTRK2 in nicotine dependence.How can we use our knowledge of alcohol-tobacco interactions to reduce alcohol use?Effects of short-term varenicline administration on emotional and cognitive processing in healthy, non-smoking adults: a randomized, double-blind, studyInsights into the neurobiology of the nicotinic cholinergic system and nicotine addiction from mice expressing nicotinic receptors harboring gain-of-function mutationsEffects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.Genetic variability in nicotinic acetylcholine receptors and nicotine addiction: converging evidence from human and animal research.
P2860
Q24620757-261F2866-F4E7-4288-AA98-A96D1AFBE7A6Q24626554-4FFDAA0C-265F-413A-A860-A92DE224A0BDQ24632974-EE6B5442-F670-4FFB-97BA-B825F7801D70Q24641901-DECDAD48-8DB0-417B-ACA1-87C0D94A103DQ24643170-2C6E3762-D637-41BA-99F8-A587ECC4CC84Q24647069-19D92E44-6047-4214-A06A-1A4C2215508EQ24650892-709671C5-648F-4D84-96EF-330A9A2F1448Q26751374-C110ED6F-7F5B-49CB-BD84-FEE80F729B31Q26851972-286B23EB-219E-4FEA-873B-EE8212EF5B58Q27008063-BE6CDAE0-4C2D-43E6-9EFC-A56D22C76E08Q27010347-3026B59F-F6E3-48DA-9255-280C0FA8DB96Q27021772-1192A068-9D0A-433C-AE8E-A10F04A09C55Q27313825-307550FB-FB31-4B70-9E95-527D5A94F96BQ27345275-978BD156-9325-4258-A9A1-61F6AE7423F3Q27679259-0F2ED6B7-EC22-426C-89B3-F6330900735FQ27728171-42F7DBAF-8833-4A29-947C-A0687CED0FB8Q28072077-0C50F8BD-87BA-4D58-8249-55166DED345CQ28084459-96230064-773B-40DC-916E-7FBC35B35AA4Q28087047-D57BECC5-6CB4-4373-BF21-EFDB3AAD07C3Q28238267-B4A0DD86-72EC-4B8D-8511-86C981F4EA87Q28253308-5024576A-0137-4F8E-B89C-68AAF1CC4B2EQ28265155-A0F75E60-CC6B-49F4-B8BE-7F7AF1BFB500Q28267832-C560149C-94F2-4795-992A-412F5E607DF1Q28281281-9D75A057-BEFE-4014-B2C5-4DB1D3A17058Q28300210-9E41B595-B1EF-406A-9FAC-65133F4D96E7Q28473095-44ECA315-0296-44FF-B92A-34BE1B690B7BQ28477118-F1076416-B893-4C9D-B657-92572095BB7BQ28484969-81467DA4-F2DA-4567-834B-FE8D47E36FFCQ28592960-BC49CFDE-A511-4AA7-B4C8-656800C4587FQ28741473-79CE50A1-20B8-455A-A438-6F996C354E37Q30365559-A5E40354-B4E4-4873-8290-E1FAE6E87269Q30396291-C8178F2A-A335-458C-8738-A0BAEB767B88Q30417717-0020946C-BBF0-4842-ADEB-6D5806A0A8E8Q30435949-67047012-0701-44E8-806C-A297946AEDE4Q30437713-EFC756D3-8109-4162-9CBC-F6BFAB98BAA6Q30441131-81277AAF-2E27-47A5-86E0-D72C37C8CCB3Q30443702-44862B77-6697-49E2-A20D-F08666D8ADC1Q30448803-38959478-0DCE-43B9-AB1C-EAAA26A9E81AQ30455599-38FF8511-FC03-4B9F-96A7-2AE52DDF4D53Q30485478-D56A3E16-5C3B-4C23-9A4B-6595DB77A29D
P2860
Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization
description
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Science
@fr
artículu científicu espublizáu en 2004
@ast
im November 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2004/11/05)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/11/05)
@nl
наукова стаття, опублікована в листопаді 2004
@uk
name
Nicotine activation of alpha4* ...... , tolerance, and sensitization
@ast
Nicotine activation of alpha4* ...... , tolerance, and sensitization
@en
Nicotine activation of alpha4* ...... , tolerance, and sensitization
@nl
type
label
Nicotine activation of alpha4* ...... , tolerance, and sensitization
@ast
Nicotine activation of alpha4* ...... , tolerance, and sensitization
@en
Nicotine activation of alpha4* ...... , tolerance, and sensitization
@nl
prefLabel
Nicotine activation of alpha4* ...... , tolerance, and sensitization
@ast
Nicotine activation of alpha4* ...... , tolerance, and sensitization
@en
Nicotine activation of alpha4* ...... , tolerance, and sensitization
@nl
P2093
P3181
P356
P1433
P1476
Nicotine activation of alpha4* ...... , tolerance, and sensitization
@en
P2093
Allan C. Collins
Andrew R. Tapper
Cesar Labarca
Henry A. Lester
Johannes Schwarz
Michael J. Marks
Paul Whiteaker
Purnima Deshpande
Raad Nashmi
Sheri L. McKinney
P304
P3181
P356
10.1126/SCIENCE.1099420
P407
P577
2004-11-05T00:00:00Z